Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Sanofi (OTC: SNYNF).

Full DD Report for SNYNF

You must become a subscriber to view this report.


Recent News from (OTC: SNYNF)

NICE Recommends Sanofi's New Treatment Dupixent(R) ? (dupilumab) for Adults with Moderate to Severe Atopic Dermatitis in England[1]
GUILDFORD, England , June 22, 2018 /PRNewswire/ -- - Positive recommendation for Dupixent [ R] (dupilumab) in F inal A ppraisal D etermination (FAD) paves the way for the first targeted biologic for adults with moderate to severe atopic dermatitis - Atopic dermati...
Source: PR Newswire
Date: June, 22 2018 02:00
New England Journal of Medicine Publishes Cemiplimab Trial Results in Advanced Cutaneous Squamous Cell Carcinoma[1]
GUILDFORD, England , June 5, 2018 /PRNewswire/ -- - Patients treated with cemiplimab experienced robust anti-tumour effects[1] - Data also presented today at the 2018 ASCO Annual Meeting[2],[3] - Cemipli...
Source: PR Newswire
Date: June, 05 2018 02:00
It Affects Over 1.5 Million People in the UK. [1],[2] In a Survey, 80% Report that it Impacts their Mood, Mental Health and Well-Being. But What is Atopic Dermatitis?
GUILDFORD, England , May 15, 2018 /PRNewswire/ -- Not intended for Irish media Atopic dermatitis is the most common type of eczema [3] New public awareness campaign  Scratch Beneath the Surface  uncovers the real impact of atopic dermatitis UK-wide survey of people wi...
Source: PR Newswire
Date: May, 15 2018 02:00
'Safer' Dividend Healthcare Top Gainers Are AbbVie, Sanofi, Lilly, Gilead, & Novartis (All BPh) Per Broker Targets To April 2019
Actionable Conclusions (1-10): Brokers Estimated Top Ten Healthcare "Safer" Dividend Stocks to Net 15.6% to 33.7% Gains To April, 2019 Four of ten top 'safer' dividend Healthcare dogs by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year....
Source: SeekingAlpha
Date: April, 10 2018 13:25
Dividend Gainers: Sanofi, Lilly, Johnson & Johnson, & Gilead Are Tops Per Broker Targets To February 2019
Actionable Conclusions (1-10): Brokers Calculated Top Ten Healthcare "Safer" Dividend Stocks to Net 1.95% to 26.43% Gains To February, 2019 Six of ten top 'safer' dividend Healthcare dogs by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming y...
Source: SeekingAlpha
Date: March, 01 2018 16:59
Big Pharma Rules 'Safer' Dividend Healthcare Top Gains Per Broker Targets To January
Actionable Conclusions (1-10): Brokers Calculated Top Ten Healthcare "Safer" Dividend Stocks to Net 1.64% to 13.34% Gains To January, 2019 Four of ten top 'safer' dividend Healthcare dogs by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming y...
Source: SeekingAlpha
Date: January, 28 2018 13:13

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-11N/A88.40N/AN/A85
2018-12-1088.4088.4088.4088.40200
2018-12-0785.6085.6085.6085.60165
2018-12-0685.7986.9086.9085.79620
2018-12-0589.3989.3989.3989.39548

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10200200100.0000Short
2018-12-0620062032.2581Cover
2018-11-30122122100.0000Short
2018-11-1547151591.4563Short
2018-11-0920025080.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SNYNF.


About Sanofi (OTC: SNYNF)

Logo for Sanofi (OTC: SNYNF)

Not available

 

Contact Information

 

 

Current Management

  • JeanFrancois Dehecq / CEO
  • Hanspeter Spek / COO
  • Pierre Lepienne / Secretary

Current Share Structure

     


    Recent Filings from (OTC: SNYNF)

    Post-effective amendment to an S-8 filing
    Filing Type: S-8 POSFiling Source: edgar
    Filing Date: May, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: May, 03 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 27 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 24 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 18 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 03 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: March, 29 2018
    Amendment to a previously filed 20-F
    Filing Type: 20-F/AFiling Source: edgar
    Filing Date: March, 16 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: March, 15 2018
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: March, 12 2018

     

     


    Daily Technical Chart for (OTC: SNYNF)

    Daily Technical Chart for (OTC: SNYNF)


    Stay tuned for daily updates and more on (OTC: SNYNF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: SNYNF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SNYNF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SNYNF and does not buy, sell, or trade any shares of SNYNF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/